Kramer Levin represented Leading Pharma LLC, a privately owned generic pharmaceutical company, in a $40 million growth capital financing transaction. New investors included Signet Healthcare Partners, Crestline Investors and Cane Investment Partners, in addition to existing equity holders. The capital raise closed on December 28, 2017.